 Samer Al-Khudari
Concepts (200)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Squamous Cell | 10 | 2022 | 207 | 4.970 |
Why?
| | Head and Neck Neoplasms | 12 | 2023 | 141 | 4.340 |
Why?
| | Parotid Neoplasms | 3 | 2021 | 13 | 2.420 |
Why?
| | Oropharyngeal Neoplasms | 4 | 2022 | 23 | 2.280 |
Why?
| | Tongue Neoplasms | 3 | 2021 | 17 | 2.260 |
Why?
| | Laryngeal Neoplasms | 5 | 2023 | 34 | 2.170 |
Why?
| | Robotic Surgical Procedures | 3 | 2020 | 25 | 1.970 |
Why?
| | Neck Dissection | 3 | 2021 | 18 | 1.400 |
Why?
| | Adenocarcinoma | 2 | 2021 | 231 | 1.390 |
Why?
| | Neoplasm Recurrence, Local | 6 | 2022 | 244 | 1.210 |
Why?
| | Facial Nerve | 3 | 2021 | 13 | 1.200 |
Why?
| | Parotid Gland | 3 | 2021 | 18 | 1.200 |
Why?
| | Retrospective Studies | 23 | 2023 | 3835 | 1.190 |
Why?
| | Dissection | 3 | 2021 | 29 | 1.190 |
Why?
| | Lymphatic Metastasis | 3 | 2021 | 101 | 1.140 |
Why?
| | Salvage Therapy | 3 | 2023 | 48 | 1.070 |
Why?
| | Papillomavirus Infections | 2 | 2022 | 38 | 1.000 |
Why?
| | Drug Utilization | 2 | 2020 | 27 | 0.960 |
Why?
| | Narcotics | 2 | 2020 | 35 | 0.930 |
Why?
| | Analgesia | 2 | 2020 | 40 | 0.920 |
Why?
| | Postoperative Complications | 5 | 2020 | 1117 | 0.920 |
Why?
| | Alphapapillomavirus | 1 | 2022 | 6 | 0.890 |
Why?
| | Survival Rate | 8 | 2021 | 443 | 0.840 |
Why?
| | Humans | 37 | 2023 | 32988 | 0.830 |
Why?
| | Gloves, Surgical | 1 | 2021 | 7 | 0.810 |
Why?
| | Neoplasm Seeding | 1 | 2021 | 7 | 0.810 |
Why?
| | Adenolymphoma | 1 | 2020 | 4 | 0.800 |
Why?
| | Adenoma, Pleomorphic | 1 | 2020 | 6 | 0.800 |
Why?
| | Surgical Instruments | 1 | 2021 | 30 | 0.800 |
Why?
| | Otorhinolaryngologic Surgical Procedures | 1 | 2021 | 28 | 0.790 |
Why?
| | Glottis | 1 | 2020 | 5 | 0.790 |
Why?
| | Digestive System Surgical Procedures | 1 | 2020 | 27 | 0.790 |
Why?
| | Neoplasm Grading | 2 | 2021 | 56 | 0.780 |
Why?
| | Prescriptions | 1 | 2020 | 20 | 0.770 |
Why?
| | Sarcoma | 1 | 2021 | 76 | 0.740 |
Why?
| | Chemoradiotherapy | 3 | 2023 | 72 | 0.730 |
Why?
| | Pain, Postoperative | 2 | 2020 | 321 | 0.730 |
Why?
| | Human papillomavirus 16 | 1 | 2019 | 8 | 0.720 |
Why?
| | Male | 24 | 2021 | 17726 | 0.720 |
Why?
| | Pharyngeal Neoplasms | 1 | 2019 | 5 | 0.720 |
Why?
| | Pharyngectomy | 1 | 2019 | 4 | 0.720 |
Why?
| | Middle Aged | 20 | 2021 | 11219 | 0.710 |
Why?
| | Biopsy, Fine-Needle | 1 | 2019 | 55 | 0.700 |
Why?
| | Aged | 19 | 2023 | 10542 | 0.700 |
Why?
| | Recovery of Function | 1 | 2020 | 312 | 0.700 |
Why?
| | Female | 22 | 2021 | 18423 | 0.640 |
Why?
| | Databases, Factual | 4 | 2021 | 393 | 0.540 |
Why?
| | Tonsillar Neoplasms | 1 | 2014 | 3 | 0.510 |
Why?
| | Meningeal Neoplasms | 1 | 2014 | 15 | 0.500 |
Why?
| | Laryngectomy | 4 | 2023 | 19 | 0.500 |
Why?
| | Dura Mater | 1 | 2014 | 22 | 0.490 |
Why?
| | Teratoma | 1 | 2012 | 5 | 0.460 |
Why?
| | Adult | 13 | 2020 | 9848 | 0.450 |
Why?
| | Surgical Flaps | 1 | 2012 | 53 | 0.440 |
Why?
| | Laryngeal Edema | 1 | 2011 | 2 | 0.430 |
Why?
| | Angioedema | 1 | 2011 | 4 | 0.430 |
Why?
| | Airway Obstruction | 1 | 2011 | 21 | 0.420 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 1 | 2011 | 32 | 0.420 |
Why?
| | Ear Diseases | 1 | 2011 | 3 | 0.420 |
Why?
| | Laryngeal Diseases | 1 | 2011 | 4 | 0.420 |
Why?
| | Nose Diseases | 1 | 2011 | 9 | 0.420 |
Why?
| | Neoplasm Staging | 4 | 2021 | 457 | 0.410 |
Why?
| | Nose Neoplasms | 2 | 2022 | 34 | 0.410 |
Why?
| | Gravitation | 1 | 2010 | 1 | 0.410 |
Why?
| | Barotrauma | 1 | 2010 | 3 | 0.410 |
Why?
| | Accidents | 1 | 2010 | 4 | 0.410 |
Why?
| | Tympanic Membrane | 1 | 2010 | 4 | 0.400 |
Why?
| | Ear Canal | 1 | 2010 | 4 | 0.400 |
Why?
| | Head Movements | 1 | 2010 | 9 | 0.400 |
Why?
| | Leisure Activities | 1 | 2010 | 14 | 0.400 |
Why?
| | Tongue | 2 | 2021 | 9 | 0.400 |
Why?
| | Acceleration | 1 | 2010 | 26 | 0.400 |
Why?
| | Edema | 1 | 2010 | 39 | 0.390 |
Why?
| | Hypersensitivity | 1 | 2011 | 58 | 0.390 |
Why?
| | Chylothorax | 1 | 2010 | 2 | 0.380 |
Why?
| | Prognosis | 3 | 2019 | 1011 | 0.370 |
Why?
| | Neoplasm Invasiveness | 2 | 2021 | 92 | 0.370 |
Why?
| | Papillomaviridae | 2 | 2022 | 30 | 0.360 |
Why?
| | Proportional Hazards Models | 2 | 2021 | 387 | 0.360 |
Why?
| | Cohort Studies | 4 | 2020 | 2077 | 0.340 |
Why?
| | Disease-Free Survival | 2 | 2019 | 228 | 0.340 |
Why?
| | United States | 6 | 2021 | 2632 | 0.340 |
Why?
| | Young Adult | 6 | 2020 | 2287 | 0.330 |
Why?
| | Lens Cortex, Crystalline | 1 | 2007 | 3 | 0.330 |
Why?
| | Lens Nucleus, Crystalline | 1 | 2007 | 6 | 0.330 |
Why?
| | Coronavirus Infections | 2 | 2020 | 96 | 0.330 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 101 | 0.330 |
Why?
| | Lens, Crystalline | 1 | 2007 | 31 | 0.320 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2018 | 25 | 0.300 |
Why?
| | Risk Assessment | 2 | 2019 | 814 | 0.280 |
Why?
| | Treatment Outcome | 3 | 2020 | 4036 | 0.280 |
Why?
| | Adolescent | 4 | 2020 | 2687 | 0.280 |
Why?
| | Otolaryngology | 2 | 2020 | 32 | 0.240 |
Why?
| | Free Tissue Flaps | 2 | 2019 | 14 | 0.230 |
Why?
| | SEER Program | 2 | 2019 | 42 | 0.230 |
Why?
| | Pilot Projects | 2 | 2022 | 466 | 0.220 |
Why?
| | Cell-Derived Microparticles | 1 | 2022 | 6 | 0.220 |
Why?
| | Paranasal Sinus Neoplasms | 1 | 2022 | 55 | 0.220 |
Why?
| | Combined Modality Therapy | 2 | 2021 | 449 | 0.210 |
Why?
| | Age Factors | 3 | 2019 | 932 | 0.210 |
Why?
| | Aged, 80 and over | 5 | 2020 | 5249 | 0.210 |
Why?
| | Prospective Studies | 2 | 2021 | 2002 | 0.200 |
Why?
| | Chondrosarcoma | 1 | 2021 | 38 | 0.200 |
Why?
| | Cytological Techniques | 1 | 2021 | 17 | 0.200 |
Why?
| | Length of Stay | 2 | 2023 | 382 | 0.200 |
Why?
| | Pain Measurement | 2 | 2020 | 479 | 0.200 |
Why?
| | Otorhinolaryngologic Diseases | 1 | 2020 | 8 | 0.190 |
Why?
| | Esthesioneuroblastoma, Olfactory | 1 | 2020 | 11 | 0.190 |
Why?
| | Urban Health Services | 1 | 2020 | 18 | 0.190 |
Why?
| | Clinical Laboratory Techniques | 1 | 2020 | 38 | 0.190 |
Why?
| | Paraganglioma | 1 | 2019 | 4 | 0.190 |
Why?
| | Sentinel Lymph Node Biopsy | 1 | 2019 | 19 | 0.180 |
Why?
| | Genetic Heterogeneity | 1 | 2019 | 9 | 0.180 |
Why?
| | Head | 1 | 2019 | 23 | 0.180 |
Why?
| | Larynx | 1 | 2019 | 14 | 0.180 |
Why?
| | Neck | 1 | 2019 | 32 | 0.180 |
Why?
| | Preoperative Care | 1 | 2020 | 148 | 0.180 |
Why?
| | Medical Illustration | 1 | 2019 | 20 | 0.180 |
Why?
| | Pharynx | 1 | 2019 | 14 | 0.180 |
Why?
| | Lymph Nodes | 1 | 2019 | 84 | 0.180 |
Why?
| | Risk Factors | 3 | 2021 | 2762 | 0.180 |
Why?
| | Kaplan-Meier Estimate | 1 | 2019 | 216 | 0.180 |
Why?
| | Disease Management | 1 | 2020 | 138 | 0.170 |
Why?
| | Sweat Gland Neoplasms | 1 | 2018 | 3 | 0.170 |
Why?
| | Thyroid Neoplasms | 1 | 2019 | 50 | 0.170 |
Why?
| | Morphine | 1 | 2019 | 79 | 0.170 |
Why?
| | Reference Values | 1 | 2019 | 250 | 0.170 |
Why?
| | Multivariate Analysis | 1 | 2019 | 386 | 0.170 |
Why?
| | Follow-Up Studies | 2 | 2020 | 2053 | 0.160 |
Why?
| | Carcinoma | 1 | 2018 | 77 | 0.160 |
Why?
| | Telemedicine | 1 | 2020 | 117 | 0.160 |
Why?
| | Aging | 1 | 2007 | 1634 | 0.160 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 592 | 0.160 |
Why?
| | Frozen Sections | 1 | 2017 | 11 | 0.150 |
Why?
| | Aspergillosis | 1 | 2017 | 11 | 0.150 |
Why?
| | Mucormycosis | 1 | 2017 | 8 | 0.150 |
Why?
| | Analgesics, Opioid | 1 | 2019 | 224 | 0.150 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 24 | 0.140 |
Why?
| | Markov Chains | 1 | 2015 | 31 | 0.140 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2015 | 81 | 0.140 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 159 | 0.130 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 120 | 0.130 |
Why?
| | Rhinitis | 1 | 2017 | 177 | 0.120 |
Why?
| | Neoplasm Proteins | 1 | 2014 | 58 | 0.120 |
Why?
| | Radiotherapy Dosage | 1 | 2014 | 147 | 0.120 |
Why?
| | Sinusitis | 1 | 2017 | 201 | 0.120 |
Why?
| | Cricoid Cartilage | 1 | 2012 | 1 | 0.110 |
Why?
| | Drainage | 2 | 2010 | 56 | 0.110 |
Why?
| | Immunohistochemistry | 1 | 2014 | 471 | 0.110 |
Why?
| | Forearm | 1 | 2012 | 18 | 0.110 |
Why?
| | Diagnosis, Differential | 2 | 2011 | 462 | 0.110 |
Why?
| | Trachea | 1 | 2012 | 27 | 0.110 |
Why?
| | Tongue Diseases | 1 | 2011 | 1 | 0.110 |
Why?
| | Mouth Floor | 1 | 2011 | 2 | 0.110 |
Why?
| | Laryngoscopy | 1 | 2011 | 23 | 0.110 |
Why?
| | Organ Transplantation | 1 | 2012 | 43 | 0.110 |
Why?
| | Patient Admission | 1 | 2011 | 30 | 0.110 |
Why?
| | Otoscopy | 1 | 2010 | 1 | 0.100 |
Why?
| | Skin Neoplasms | 1 | 2012 | 86 | 0.100 |
Why?
| | Remission, Spontaneous | 1 | 2010 | 10 | 0.100 |
Why?
| | Hearing Tests | 1 | 2010 | 10 | 0.100 |
Why?
| | Intubation, Intratracheal | 1 | 2011 | 75 | 0.100 |
Why?
| | Mediastinal Diseases | 1 | 2010 | 5 | 0.090 |
Why?
| | Hematoma | 1 | 2010 | 25 | 0.090 |
Why?
| | Emergency Service, Hospital | 1 | 2011 | 191 | 0.090 |
Why?
| | Algorithms | 1 | 2011 | 428 | 0.090 |
Why?
| | Recurrence | 1 | 2010 | 400 | 0.090 |
Why?
| | Intensive Care Units | 1 | 2011 | 339 | 0.090 |
Why?
| | Lasers | 1 | 2007 | 17 | 0.080 |
Why?
| | Embryo, Mammalian | 1 | 2007 | 36 | 0.080 |
Why?
| | Pandemics | 2 | 2020 | 253 | 0.080 |
Why?
| | Microscopy, Electron, Scanning | 1 | 2007 | 91 | 0.080 |
Why?
| | Scattering, Radiation | 1 | 2007 | 41 | 0.080 |
Why?
| | Fetus | 1 | 2007 | 66 | 0.080 |
Why?
| | Hypertension | 1 | 2010 | 293 | 0.080 |
Why?
| | Rabbits | 1 | 2007 | 336 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 2 | 2022 | 899 | 0.060 |
Why?
| | Biology | 1 | 2022 | 7 | 0.060 |
Why?
| | Apoptosis | 1 | 2022 | 288 | 0.050 |
Why?
| | Disease Transmission, Infectious | 1 | 2020 | 22 | 0.050 |
Why?
| | Survival Analysis | 1 | 2021 | 372 | 0.050 |
Why?
| | Nasal Cavity | 1 | 2020 | 35 | 0.050 |
Why?
| | Genomics | 1 | 2020 | 51 | 0.050 |
Why?
| | Emergencies | 1 | 2020 | 44 | 0.050 |
Why?
| | Tertiary Care Centers | 1 | 2020 | 81 | 0.050 |
Why?
| | Socioeconomic Factors | 1 | 2021 | 364 | 0.050 |
Why?
| | Mass Screening | 1 | 2020 | 203 | 0.040 |
Why?
| | Animals | 1 | 2007 | 5371 | 0.040 |
Why?
| | Mucor | 1 | 2017 | 4 | 0.040 |
Why?
| | Aspergillus | 1 | 2017 | 7 | 0.040 |
Why?
| | Nasal Surgical Procedures | 1 | 2017 | 8 | 0.040 |
Why?
| | Sex Factors | 1 | 2019 | 548 | 0.040 |
Why?
| | Chicago | 1 | 2020 | 957 | 0.040 |
Why?
| | Immunocompromised Host | 1 | 2017 | 54 | 0.040 |
Why?
| | Nose | 1 | 2017 | 36 | 0.040 |
Why?
| | Acute Disease | 1 | 2017 | 258 | 0.040 |
Why?
| | Endoscopy | 1 | 2017 | 188 | 0.030 |
Why?
| | Treatment Failure | 1 | 2015 | 186 | 0.030 |
Why?
| | Decision Making | 1 | 2017 | 239 | 0.030 |
Why?
| | Registries | 1 | 2015 | 226 | 0.030 |
Why?
|
|
Al-Khudari's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|